{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:14:35Z","timestamp":1794485675747,"version":"4.9.1"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Schizophr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptor hypofunction is one of the most prevalent models of schizophrenia. For example, healthy subjects treated with uncompetitive\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptor antagonists elicit positive, negative, and cognitive-like symptoms of schizophrenia. Patients with anti-\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptor encephalitis, which is likely caused by autoantibody-mediated down-regulation of cell surface\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptors, often experience psychiatric symptoms similar to schizophrenia initially. However, where and when\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptor hypofunction occurs in the brain of schizophrenic patients is poorly understood. Here we review the findings from\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d-<\/jats:sc>\n                    aspartate receptor antagonist and autoantibody models, postmortem studies on\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptor subunits, as well as the global and cell-type-specific knockout mouse models of subunit GluN1. We compare various conditional GluN1 knockout mouse strains, focusing on the onset of\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptor deletion and on the cortical cell-types. Based on these results, we hypothesize that\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptor hypofunction initially occurs in cortical GABAergic neurons during early postnatal development. The resulting GABA neuron maturation deficit may cause reduction of intrinsic excitability and GABA release, leading to disinhibition of pyramidal neurons. The cortical disinhibition in turn could elicit glutamate spillover and subsequent homeostatic down regulation of\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptor function in pyramidal neurons in prodromal stage. These two temporally-distinct\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptor hypofunctions may be complimentary, as neither alone may not be able to fully explain the entire schizophrenia pathophysiology. Potential underlying mechanisms for\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptor hypofunction in cortical GABA neurons are also discussed, based on studies of naturally-occurring\n                    <jats:italic>N<\/jats:italic>\n                    -methyl-\n                    <jats:sc>d<\/jats:sc>\n                    -aspartate receptor antagonists, neuregulin\/ErbB4 signaling pathway, and theoretical analysis of excitatory\/inhibitory balance.\n                  <\/jats:p>","DOI":"10.1038\/s41537-016-0003-3","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T11:13:06Z","timestamp":1485515586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia"],"prefix":"10.1038","volume":"3","author":[{"given":"Kazu","family":"Nakazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Jeevakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes, O. D. & Kapur, S. The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr. Bull. \n                           35, 549\u2013562 (2009).","journal-title":"Schizophr. Bull."},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/schbul\/sbs076","volume":"38","author":"JT Coyle","year":"2012","unstructured":"Coyle, J. T. NMDA receptor and schizophrenia: a brief history. Schizophr. Bull. \n                           38, 920\u2013926 (2012).","journal-title":"Schizophr. Bull."},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1111\/bph.13222","volume":"172","author":"D Lodge","year":"2015","unstructured":"Lodge, D. & Mercier, M. S. Ketamine and phencyclidine: the good, the bad and the unexpected. Br. J. Pharmacol. \n                           172, 4254\u20134276 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"3_CR4","unstructured":"PCP\u00a0(Phencyclidine):\u00a0Historical and Current Perspectives,\u00a0Edward F.\u00a0Domino, ed. NPP Books, Ann Arbor, USA (1981)."},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","volume":"13","author":"AC Lahti","year":"1995","unstructured":"Lahti, A. C. et al. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. \n                           13, 9\u201319 (1995).","journal-title":"Neuropsychopharmacology."},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1177\/0269881113495117","volume":"27","author":"MJ Hunt","year":"2013","unstructured":"Hunt, M. J. & Kasicki, S. A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo. J. Psychopharmacol. \n                           27, 972\u2013986 (2013).","journal-title":"J. Psychopharmacol."},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/mp.2012.194","volume":"18","author":"NR Driesen","year":"2013","unstructured":"Driesen, N. R. et al. Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Mol. Psychiatry \n                           18, 1199\u20131204 (2013).","journal-title":"Mol. Psychiatry"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"723184","DOI":"10.1155\/2011\/723184","volume":"2011","author":"G Gonzalez-Burgos","year":"2011","unstructured":"Gonzalez-Burgos, G., Fish, K. N. & Lewis, D. A. GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast. \n                           2011, 723184 (2011).","journal-title":"Neural Plast."},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/mp.2011.171","volume":"17","author":"JM Stone","year":"2012","unstructured":"Stone, J. M. et al. Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology. Mol. Psychiatry \n                           17, 664\u2013665 (2012).","journal-title":"Mol. Psychiatry"},{"key":"3_CR10","doi-asserted-by":"crossref","unstructured":"Merritt K. et al. Nature of Glutamate alterations in schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies. JAMA Psychiatry \n                           73, 665\u2013674\u00a0(2016).","DOI":"10.1001\/jamapsychiatry.2016.0442"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"8467","DOI":"10.1073\/pnas.0308455101","volume":"101","author":"ME Jackson","year":"2004","unstructured":"Jackson, M. E., Homayoun, H. & Moghaddam, B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc. Natl. Acad. Sci. USA \n                           101, 8467\u20138472 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","volume":"27","author":"H Homayoun","year":"2007","unstructured":"Homayoun, H. & Moghaddam, B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J. Neurosci. \n                           27, 11496\u201311500 (2007).","journal-title":"J. Neurosci."},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/0028-3908(87)90087-6","volume":"26","author":"A Gratton","year":"1987","unstructured":"Gratton, A., Hoffer, B. J. & Freedman, R. Electrophysiological effects of phencyclidine in the medial prefrontal cortex of the rat. Neuropharmacology \n                           26, 1275\u20131283 (1987).","journal-title":"Neuropharmacology"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0306-4522(02)00298-1","volume":"114","author":"Y Suzuki","year":"2002","unstructured":"Suzuki, Y. et al. Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats. Neuroscience \n                           114, 769\u2013779 (2002).","journal-title":"Neuroscience"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/cercor\/bhh168","volume":"15","author":"E Jodo","year":"2005","unstructured":"Jodo, E. et al. Activation of medial prefrontal cortex by phencyclidine is mediated via a hippocampo-prefrontal pathway. Cereb. Cortex \n                           15, 663\u2013669 (2005).","journal-title":"Cereb. Cortex"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jphysparis.2013.06.002","volume":"107","author":"E Jodo","year":"2013","unstructured":"Jodo, E. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia. J. Physiol. Paris \n                           107, 434\u2013440 (2013).","journal-title":"J. Physiol. Paris"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neubiorev.2015.06.022","volume":"56","author":"SA Monaco","year":"2015","unstructured":"Monaco, S. A., Gulchina, Y. & Gao, W. J. NR2B subunit in the prefrontal cortex: A double-edged sword for working memory function and psychiatric disorders. Neurosci. Biobehav. Rev. \n                           56, 127\u2013138 (2015).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.neuron.2012.12.032","volume":"77","author":"M Wang","year":"2013","unstructured":"Wang, M. et al. NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex. Neuron \n                           77, 736\u2013749 (2013).","journal-title":"Neuron"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrn1385","volume":"5","author":"K Nakazawa","year":"2004","unstructured":"Nakazawa, K. et al. NMDA receptors, place cells and hippocampal spatial memory. Nat. Rev. Neurosci. \n                           5, 361\u2013372 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1523\/JNEUROSCI.09-07-02382.1989","volume":"9","author":"LT Thompson","year":"1989","unstructured":"Thompson, L. T. & Best, P. J. Place cells and silent cells in the hippocampus of freely-behaving rats. J. Neurosci. \n                           9, 2382\u20132390 (1989).","journal-title":"J. Neurosci."},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1113\/jphysiol.2012.245852","volume":"591","author":"N Le Roux","year":"2013","unstructured":"Le Roux, N. et al. Input-specific learning rules at excitatory synapses onto hippocampal parvalbumin-expressing interneurons. J. Physiol. \n                           591, 1809\u20131822 (2013).","journal-title":"J. Physiol."},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/nn.3459","volume":"16","author":"JA Matta","year":"2013","unstructured":"Matta, J. A. et al. Developmental origin dictates interneuron AMPA and NMDA receptor subunit composition and plasticity. Nat. Neurosci. \n                           16, 1032\u20131041 (2013).","journal-title":"Nat. Neurosci."},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-4328(00)00138-8","volume":"111","author":"J Ma","year":"2000","unstructured":"Ma, J. & Leung, L. S. Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine. Behav. Brain Res. \n                           111, 1\u201311 (2000).","journal-title":"Behav. Brain Res."},{"issue":"3","key":"3_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.neuron.2010.09.017","volume":"68","author":"T Korotkova","year":"2010","unstructured":"Korotkova, T. et al. NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron \n                           68(3), 557\u2013569 (2010).","journal-title":"Neuron"},{"issue":"2","key":"3_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/ejn.13128","volume":"43","author":"I Riebe","year":"2016","unstructured":"Riebe, I. et al. Tonically active NMDA receptors--a signalling mechanism critical for interneuronal excitability in the CA1 stratum radiatum. Eur. J. Neurosci. \n                           43(2), 169\u2013178 (2016).","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"3_CR26","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1523\/JNEUROSCI.16-06-02034.1996","volume":"16","author":"HC Grunze","year":"1996","unstructured":"Grunze, H. C. et al. NMDA-dependent modulation of CA1 local circuit inhibition. J. Neurosci. \n                           16(6), 2034\u20132043 (1996).","journal-title":"J. Neurosci."},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fncel.2015.00095","volume":"9","author":"J von Engelhardt","year":"2015","unstructured":"von Engelhardt, J. et al. GluN2D-containing NMDA receptors-mediate synaptic currents in hippocampal interneurons and pyramidal cells in juvenile mice. Front Cell Neurosci. \n                           9, 95 (2015).","journal-title":"Front Cell Neurosci."},{"issue":"9","key":"3_CR28","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1523\/JNEUROSCI.3703-08.2009","volume":"29","author":"SE Kotermanski","year":"2009","unstructured":"Kotermanski, S. E. & Johnson, J. W. Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine. J. Neurosci. \n                           29(9), 2774\u20132779 (2009).","journal-title":"J. Neurosci."},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"e13722","DOI":"10.1371\/journal.pone.0013722","volume":"5","author":"Y Hagino","year":"2010","unstructured":"Hagino, Y. et al. Essential role of NMDA receptor channel \u03b54 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine. PLoS One \n                           5, e13722 (2010).","journal-title":"PLoS One"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1756-6606-6-56","volume":"6","author":"H Yamamoto","year":"2013","unstructured":"Yamamoto, H. et al. Involvement of the N-methyl-D-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity. Mol. Brain. \n                           6, 56 (2013).","journal-title":"Mol Brain"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2015.10.049","volume":"610","author":"T Yamamoto","year":"2016","unstructured":"Yamamoto, T. et al. Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase. Neurosci. Lett. \n                           610, 48\u201353 (2016).","journal-title":"Neurosci. Lett."},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1124\/jpet.115.230391","volume":"356","author":"K Sapkota","year":"2016","unstructured":"Sapkota, K. et al. GluN2D N-methyl-D-aspartate receptor subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine: implications for schizophrenia. J. Pharmacol. Exp. Ther. \n                           356, 702\u2013711 (2016).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1126\/science.277.5328.953","volume":"277","author":"JD Jentsch","year":"1997","unstructured":"Jentsch, J. D. et al. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science \n                           277, 953\u2013955 (1997).","journal-title":"Science"},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/jamapsychiatry.2014.2414","volume":"72","author":"M Slifstein","year":"2015","unstructured":"Slifstein, M. et al. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry \n                           72, 316\u2013324 (2015).","journal-title":"JAMA Psychiatry"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","volume":"20","author":"JD Jentsch","year":"1999","unstructured":"Jentsch, J. D. & Roth, R. H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Europsychopharmacology \n                           20, 201\u2013225 (1999).","journal-title":"Europsychopharmacology"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.neubiorev.2008.03.012","volume":"32","author":"V Bubenikova-Valesova","year":"2008","unstructured":"Bubenikova-Valesova, V. et al. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci. Biobehav. Rev. \n                           32, 1014\u20131023 (2008).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1007\/s00213-015-3954-6","volume":"232","author":"SK Janhunen","year":"2015","unstructured":"Janhunen, S. K. et al. The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia. Psychopharmacology (Berl) \n                           232, 4059\u20134083 (2015).","journal-title":"Psychopharmacology (Berl)"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau, J. et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. \n                           10, 63\u201374 (2011).","journal-title":"Lancet Neurol."},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer, M. J. et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. \n                           12, 157\u2013165 (2013).","journal-title":"Lancet Neurol."},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau, J. et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. \n                           7, 1091\u20131098 (2008).","journal-title":"Lancet Neurol."},{"key":"3_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ana.24195","volume":"76","author":"EH Moscato","year":"2014","unstructured":"Moscato, E. H. et al. Acute echanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann. Neurol. \n                           76, 108\u2013119 (2014).","journal-title":"Ann. Neurol."},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0306-4522(03)00157-X","volume":"119","author":"G Nyiri","year":"2003","unstructured":"Nyiri, G. et al. Large variability in synaptic N-methyl-D-aspartate receptor density on interneurons and a comparison with pyramidal-cell spines in the rat hippocampus. Neuroscience. \n                           119, 347\u2013363 (2003).","journal-title":"Neuroscience."},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tins.2016.02.006","volume":"39","author":"JC Masdeu","year":"2016","unstructured":"Masdeu, J. C., Dalmau, J. & Berman, K. F. NMDA receptor internalization by autoantibodies: a reversible mechanism underlying psychosis? Trends Neurosci. \n                           39, 11 (2016).","journal-title":"Trends Neurosci."},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas, N. et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. \n                           13, 167\u2013177 (2014).","journal-title":"Lancet Neurol."},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"1s","DOI":"10.1016\/0893-133X(95)00199-N","volume":"14","author":"DR Weinberger","year":"1996","unstructured":"Weinberger, D. R. On the plausibility of \"the neurodevelopmental hypothesis\" of schizophrenia. Neuropsychopharmacology. \n                           14, 1s\u201311s (1996).","journal-title":"Neuropsychopharmacology."},{"key":"3_CR46","first-page":"320","volume":"21","author":"SI Deutsch","year":"1998","unstructured":"Deutsch, S. I., Mastropaolo, J. & Rosse, R. B. Neurodevelopmental consequences of early exposure to phencyclidine and related drugs. Clin. Neuropharmacol. \n                           21, 320\u2013332 (1998).","journal-title":"Clin. Neuropharmacol."},{"key":"3_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","volume":"167","author":"AS Brown","year":"2010","unstructured":"Brown, A. S. & Derkits, E. J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry \n                           167, 261\u2013280 (2010).","journal-title":"Am. J. Psychiatry"},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ntt.2011.01.001","volume":"33","author":"MG Paule","year":"2011","unstructured":"Paule, M. G. et al. Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol. Teratol. \n                           33, 220\u2013230 (2011).","journal-title":"Neurotoxicol. Teratol."},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.brainresrev.2006.09.001","volume":"53","author":"TM du Bois","year":"2007","unstructured":"du Bois, T. M. & Huang, X. F. Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia. Brain Res. Rev. \n                           53, 260\u2013270 (2007).","journal-title":"Brain Res. Rev."},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.bbr.2011.10.052","volume":"227","author":"AL Lim","year":"2012","unstructured":"Lim, A. L., Taylor, D. A. & Malone, D. T. Consequences of early life MK-801 administration: long-term behavioural effects and relevance to schizophrenia research. Behav. Brain Res. \n                           227, 276\u2013286 (2012).","journal-title":"Behav. Brain Res."},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.biopsych.2005.08.029","volume":"59","author":"D Rujescu","year":"2006","unstructured":"Rujescu, D. et al. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol. Psychiatry \n                           59, 721\u2013729 (2006).","journal-title":"Biol. Psychiatry"},{"key":"3_CR52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00213-007-0729-8","volume":"192","author":"T Abekawa","year":"2007","unstructured":"Abekawa, T. et al. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats. Psychopharmacology (Berl) \n                           192, 303\u2013316 (2007).","journal-title":"Psychopharmacology (Berl)"},{"key":"3_CR53","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1126\/science.1148045","volume":"318","author":"MM Behrens","year":"2007","unstructured":"Behrens, M. M. et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science \n                           318, 1645\u20131647 (2007).","journal-title":"Science"},{"key":"3_CR54","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/sj.npp.1301647","volume":"33","author":"CZ Wang","year":"2008","unstructured":"Wang, C. Z. et al. Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons. Neuropsychopharmacology \n                           33, 2442\u20132455 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"3_CR55","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.pbb.2009.04.017","volume":"93","author":"LG Coleman Jr.","year":"2009","unstructured":"Coleman, L. G. Jr. et al. Deficits in adult prefrontal cortex neurons and behavior following early post-natal NMDA antagonist treatment. Pharmacol. Biochem. Behav. \n                           93, 322\u2013330 (2009).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"3_CR56","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1093\/cercor\/bht109","volume":"24","author":"C Kjaerby","year":"2014","unstructured":"Kjaerby, C. et al. Impaired GABAergic inhibition in the prefrontal cortex of early postnatal phencyclidine (PCP)-treated rats. Cereb. Cortex \n                           24, 2522\u20132532 (2014).","journal-title":"Cereb. Cortex"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbr.2015.01.010","volume":"282","author":"V Jeevakumar","year":"2015","unstructured":"Jeevakumar, V. et al. Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice. Behav. Brain. Res. \n                           282, 165\u2013175 (2015).","journal-title":"Behav. Brain. Res."},{"key":"3_CR58","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/cercor\/bhu293","volume":"26","author":"V Jeevakumar","year":"2016","unstructured":"Jeevakumar, V. & Kroener, S. Ketamine administration during the second postnatal week alters synaptic properties of fast-spiking interneurons in the medial prefrontal cortex of adult mice. Cereb. Cortex \n                           26, 1117\u20131129 (2016).","journal-title":"Cereb. Cortex"},{"key":"3_CR59","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0165-0173(00)00018-7","volume":"32","author":"A Contestabile","year":"2000","unstructured":"Contestabile, A. Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res. Brain Res. Rev. \n                           32, 476\u2013509 (2000).","journal-title":"Brain Res. Brain Res. Rev."},{"key":"3_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/science.8096653","volume":"260","author":"H Komuro","year":"1993","unstructured":"Komuro, H. & Rakic, P. Modulation of neuronal migration by NMDA receptors. Science \n                           260, 95\u201397 (1993).","journal-title":"Sci."},{"key":"3_CR61","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/cercor\/bhp181","volume":"20","author":"A Desfeux","year":"2010","unstructured":"Desfeux, A. et al. Dual effect of glutamate on GABAergic interneuron survival during cerebral cortex development in mice neonates. Cereb. Cortex \n                           20, 1092\u20131108 (2010).","journal-title":"Cereb. Cortex"},{"key":"3_CR62","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1046\/j.1471-4159.2003.02048.x","volume":"87","author":"M Awobuluyi","year":"2003","unstructured":"Awobuluyi, M., Lipton, S. A. & Sucher, N. J. Translationally distinct populations of NMDA receptor subunit NR1 mRNA in the developing rat brain. J. Neurochem. \n                           87, 1066\u20131075 (2003).","journal-title":"J. Neurochem."},{"key":"3_CR63","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/357686a0","volume":"357","author":"S Hestrin","year":"1992","unstructured":"Hestrin, S. Developmental regulation of NMDA receptor-mediated synaptic currents at a central synapse. Nature \n                           357, 686\u2013689 (1992).","journal-title":"Nature"},{"key":"3_CR64","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1038\/npp.2009.20","volume":"34","author":"HX Wang","year":"2009","unstructured":"Wang, H. X. & Gao, W. J. Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex. Neuropsychopharmacology \n                           34, 2028\u20132040 (2009).","journal-title":"Neuropsychopharmacology"},{"key":"3_CR65","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1523\/JNEUROSCI.1970-10.2011","volume":"31","author":"DC Rotaru","year":"2011","unstructured":"Rotaru, D. C. et al. Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia. J. Neurosci. \n                           31, 142\u2013156 (2011).","journal-title":"J. Neurosci."},{"key":"3_CR66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nn.2447","volume":"13","author":"JE Belforte","year":"2010","unstructured":"Belforte, J. E. et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. \n                           13, 76\u201383 (2010).","journal-title":"Nat. Neurosci."},{"key":"3_CR67","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1152\/jn.01017.2011","volume":"107","author":"NV Povysheva","year":"2012","unstructured":"Povysheva, N. V. & Johnson, J. W. Tonic NMDA receptor-mediated current in prefrontal cortical pyramidal cells and fast-spiking interneurons. J. Neurophysiol. \n                           107, 2232\u20132243 (2012).","journal-title":"J. Neurophysiol."},{"key":"3_CR68","doi-asserted-by":"publisher","first-page":"12956","DOI":"10.1523\/JNEUROSCI.2890-08.2008","volume":"28","author":"D Doischer","year":"2008","unstructured":"Doischer, D. et al. Postnatal differentiation of basket cells from slow to fast signaling devices. J. Neurosci. \n                           28, 12956\u201312968 (2008).","journal-title":"J. Neurosci."},{"key":"3_CR69","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/cercor\/bhq138","volume":"21","author":"EM Goldberg","year":"2011","unstructured":"Goldberg, E. M. et al. Rapid developmental maturation of neocortical FS cell intrinsic excitability. Cereb. Cortex \n                           21, 666\u2013682 (2011).","journal-title":"Cereb. Cortex"},{"key":"3_CR70","doi-asserted-by":"publisher","first-page":"e109303","DOI":"10.1371\/journal.pone.0109303","volume":"9","author":"KS Jones","year":"2014","unstructured":"Jones, K. S., Corbin, J. G. & Huntsman, M. M. Neonatal NMDA receptor blockade disrupts spike timing and glutamatergic synapses in fast spiking interneurons in a NMDA receptor hypofunction model of schizophrenia. PLoS. One \n                           9, e109303 (2014).","journal-title":"PLoS. One"},{"key":"3_CR71","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/WNR.0b013e32834d2ef7","volume":"22","author":"S Owczarek","year":"2011","unstructured":"Owczarek, S. et al. Phencyclidine treatment increases NR2A and NR2B N-methyl-D-aspartate receptor subunit expression in rats. Neuroreport \n                           22, 935\u2013938 (2011).","journal-title":"Neuroreport"},{"key":"3_CR72","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0896-6273(94)90350-6","volume":"13","author":"D Forrest","year":"1994","unstructured":"Forrest, D. et al. Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron \n                           13, 325\u2013338 (1994).","journal-title":"Neuron"},{"key":"3_CR73","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0092-8674(94)90108-2","volume":"76","author":"Y Li","year":"1994","unstructured":"Li, Y. et al. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell \n                           76, 427\u2013437 (1994).","journal-title":"Cell"},{"key":"3_CR74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0165-3806(03)00156-1","volume":"144","author":"AJ Elberger","year":"2003","unstructured":"Elberger, A. J. & Deng, J. Corpus callosum and visual cortex of mice with deletion of the NMDA-NR1 receptor: I. Accelerated development of callosal projection neurons. Brain. Res. Dev. Brain Res. \n                           144, 121\u2013133 (2003).","journal-title":"Brain. Res. Dev. Brain Res."},{"key":"3_CR75","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/jnnp.58.4.457","volume":"58","author":"PW Woodruff","year":"1995","unstructured":"Woodruff, P. W., McManus, I. C. & David, A. S. Meta-analysis of corpus callosum size in schizophrenia. J. Neurol. Neurosurg. Psychiatry \n                           58, 457\u2013461 (1995).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"3_CR76","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.schres.2008.01.005","volume":"101","author":"D Arnone","year":"2008","unstructured":"Arnone, D. et al. Meta-analysis of magnetic resonance imaging studies of the corpus callosum in schizophrenia. Schizophr. Res. \n                           101, 124\u2013132 (2008).","journal-title":"Schizophr. Res."},{"key":"3_CR77","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0092-8674(00)81972-8","volume":"98","author":"AR Mohn","year":"1999","unstructured":"Mohn, A. R. et al. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell \n                           98, 427\u2013436 (1999).","journal-title":"Cell"},{"key":"3_CR78","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0166-2236(00)01886-5","volume":"24","author":"RR Gainetdinov","year":"2001","unstructured":"Gainetdinov, R. R., Mohn, A. R. & Caron, M. G. Genetic animal models: focus on schizophrenia. Trends. Neurosci. \n                           24, 527\u2013533 (2001).","journal-title":"Trends. Neurosci."},{"key":"3_CR79","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000337984","volume":"34","author":"SS Moy","year":"2012","unstructured":"Moy, S. S. et al. Preweaning sensorimotor deficits and adolescent hypersociability in Grin1 knockdown mice. Dev. Neurosci. \n                           34, 159\u2013173 (2012).","journal-title":"Dev. Neurosci."},{"key":"3_CR80","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1601-183X.2012.00767.x","volume":"11","author":"C Barkus","year":"2012","unstructured":"Barkus, C. et al. GluN1 hypomorph mice exhibit wide-ranging behavioral alterations. Genes Brain Behav. \n                           11, 342\u2013351 (2012).","journal-title":"Genes Brain Behav."},{"key":"3_CR81","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1124\/jpet.109.150938","volume":"331","author":"CL Bodarky","year":"2009","unstructured":"Bodarky, C. L. et al. Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice. J. Pharmacol. Exp. Ther. \n                           331, 308\u2013318 (2009).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"3_CR82","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1601-183X.2012.00816.x","volume":"11","author":"MJ Gandal","year":"2012","unstructured":"Gandal, M. J. et al. Mice with reduced NMDA receptor expression: more consistent with utism than schizophrenia? Genes. Brain. Behav. \n                           11, 740\u2013750 (2012).","journal-title":"Genes Brain Behav."},{"key":"3_CR83","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1097\/00001756-199608120-00040","volume":"7","author":"C Humphries","year":"1996","unstructured":"Humphries, C. et al. NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. Neuroreport \n                           7, 2051\u20132055 (1996).","journal-title":"Neuroreport"},{"key":"3_CR84","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1046\/j.1471-4159.1998.71062454.x","volume":"71","author":"BP Sokolov","year":"1998","unstructured":"Sokolov, B. P. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of \"neuroleptic-free\" schizophrenics: evidence on reversible up-regulation by typical neuroleptics. J. Neurochem. \n                           71, 2454\u20132464 (1998).","journal-title":"J. Neurochem."},{"key":"3_CR85","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1176\/appi.ajp.157.7.1141","volume":"157","author":"XM Gao","year":"2000","unstructured":"Gao, X. M. et al. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am. J. Psychiatry \n                           157, 1141\u20131149 (2000).","journal-title":"Am. J. Psychiatry"},{"key":"3_CR86","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1176\/appi.ajp.157.11.1811","volume":"157","author":"HM Ibrahim","year":"2000","unstructured":"Ibrahim, H. M. et al. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am. J. Psychiatry \n                           157, 1811\u20131823 (2000).","journal-title":"Am. J. Psychiatry"},{"key":"3_CR87","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1097\/00001756-200109170-00043","volume":"12","author":"AJ Law","year":"2001","unstructured":"Law, A. J. & Deakin, J. F. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport \n                           12, 2971\u20132974 (2001).","journal-title":"Neuroreport"},{"key":"3_CR88","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/sj.npp.1301604","volume":"33","author":"M Beneyto","year":"2008","unstructured":"Beneyto, M. & Meador-Woodruff, J. H. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology \n                           33, 2175\u20132186 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"3_CR89","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/mp.2012.137","volume":"18","author":"CS Weickert","year":"2013","unstructured":"Weickert, C. S. et al. Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Mol. Psychiatry \n                           18, 1185\u20131192 (2013).","journal-title":"Mol. Psychiatry"},{"key":"3_CR90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1523\/JNEUROSCI.16-01-00019.1996","volume":"16","author":"S Akbarian","year":"1996","unstructured":"Akbarian, S. et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. \n                           16, 19\u201330 (1996).","journal-title":"J. Neurosci."},{"key":"3_CR91","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1176\/appi.ajp.158.9.1400","volume":"158","author":"S Dracheva","year":"2001","unstructured":"Dracheva, S. et al. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am. J. Psychiatry \n                           158, 1400\u20131410 (2001).","journal-title":"Am. J. Psychiatry"},{"key":"3_CR92","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coph.2006.08.013","volume":"7","author":"LV Kristiansen","year":"2007","unstructured":"Kristiansen, L. V. et al. NMDA receptors and schizophrenia. Curr. Opin. Pharmacol. \n                           7, 48\u201355 (2007).","journal-title":"Curr. Opin. Pharmacol."},{"key":"3_CR93","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsycho.2015.10.013","volume":"116","author":"VS Catts","year":"2016","unstructured":"Catts, V. S. et al. A quantitative review of the postmortem evidence for decreased cortical N-methyl-d-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits? Biol. Psychol. \n                           116, 57\u201367 (2016).","journal-title":"Biol. Psychol."},{"key":"3_CR94","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/mp.2014.115","volume":"20","author":"A Banerjee","year":"2015","unstructured":"Banerjee, A. et al. Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia. Mol. Psychiatry \n                           20, 1091\u20131100 (2015).","journal-title":"Mol. Psychiatry."},{"key":"3_CR95","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/35021059","volume":"406","author":"T Iwasato","year":"2000","unstructured":"Iwasato, T. et al. Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex. Nature \n                           406, 726\u2013731 (2000).","journal-title":"Nature."},{"key":"3_CR96","doi-asserted-by":"publisher","first-page":"19553","DOI":"10.1073\/pnas.0704031104","volume":"104","author":"SK Ultanir","year":"2007","unstructured":"Ultanir, S. K. et al. Regulation of spine morphology and spine density by NMDA receptor signaling in vivo. Proc. Natl. Acad. Sci. USA \n                           104, 19553\u201319558 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3_CR97","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neulet.2008.03.077","volume":"437","author":"GC Quintero","year":"2008","unstructured":"Quintero, G. C., Erzurumlu, R. S. & Vaccarino, A. L. Evaluation of morphine analgesia and motor coordination in mice following cortex-specific knockout of the N-methyl-D-aspartate NR1-subunit. Neurosci. Lett. \n                           437, 55\u201358 (2008).","journal-title":"Neurosci. Lett."},{"key":"3_CR98","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0896-6273(03)00323-4","volume":"38","author":"NB Sawtell","year":"2003","unstructured":"Sawtell, N. B. et al. NMDA receptor-dependent ocular dominance plasticity in adult visual cortex. Neuron \n                           38, 977\u2013985 (2003).","journal-title":"Neuron"},{"key":"3_CR99","doi-asserted-by":"publisher","first-page":"e61278","DOI":"10.1371\/journal.pone.0061278","volume":"8","author":"GR Rompala","year":"2013","unstructured":"Rompala, G. R. et al. Contribution of NMDA receptor hypofunction in prefrontal and cortical excitatory neurons to schizophrenia-like phenotypes. PLoS One \n                           8, e61278 (2013).","journal-title":"PLoS. One"},{"key":"3_CR100","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.biopsych.2014.06.026","volume":"77","author":"VM Tatard-Leitman","year":"2015","unstructured":"Tatard-Leitman, V. M. et al. Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability. Biol. Psychiatry \n                           77, 556\u2013568 (2015).","journal-title":"Biol. Psychiatry"},{"key":"3_CR101","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/S0092-8674(00)81827-9","volume":"87","author":"JZ Tsien","year":"1996","unstructured":"Tsien, J. Z., Huerta, P. T. & Tonegawa, S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell \n                           87, 1327\u20131338 (1996).","journal-title":"Cell"},{"key":"3_CR102","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1073\/pnas.0830996100","volume":"100","author":"M Fukaya","year":"2003","unstructured":"Fukaya, M. et al. Retention of NMDA receptor NR2 subunits in the lumen of endoplasmic reticulum in targeted NR1 knockout mice. Proc. Natl. Acad. Sci. USA \n                           100, 4855\u20134860 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3_CR103","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1460-9568.2009.06896.x","volume":"30","author":"S Jinde","year":"2009","unstructured":"Jinde, S. et al. Lack of kainic acid-induced gamma oscillations predicts subsequent CA1 excitotoxic cell death. Eur. J. Neurosci. \n                           30, 1036\u20131055 (2009).","journal-title":"Eur. J. Neurosci."},{"key":"3_CR104","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","volume":"33","author":"JW Olney","year":"1999","unstructured":"Olney, J. W., Newcomer, J. W. & Farber, N. B. NMDA receptor hypofunction model of schizophrenia. J. Psychiatr. Res. \n                           33, 523\u2013533 (1999).","journal-title":"J. Psychiatr. Res."},{"key":"3_CR105","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","volume":"31","author":"JE Lisman","year":"2008","unstructured":"Lisman, J. E. et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends. Neurosci. \n                           31, 234\u2013242 (2008).","journal-title":"Trends. Neurosci."},{"key":"3_CR106","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/schbul\/sbs010","volume":"38","author":"G Gonzalez-Burgos","year":"2012","unstructured":"Gonzalez-Burgos, G. & Lewis, D. A. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr. Bull. \n                           38, 950\u2013957 (2012).","journal-title":"Schizophr. Bull."},{"key":"3_CR107","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.neuropharm.2011.01.022","volume":"62","author":"K Nakazawa","year":"2012","unstructured":"Nakazawa, K. et al. GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology \n                           62, 1574\u20131583 (2012).","journal-title":"Neuropharmacology."},{"key":"3_CR108","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.schres.2014.12.026","volume":"167","author":"SM Cohen","year":"2015","unstructured":"Cohen, S. M. et al. The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia. Schizophr. Res. \n                           167, 98\u2013107 (2015).","journal-title":"Schizophr. Res."},{"key":"3_CR109","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1523\/JNEUROSCI.2279-14.2015","volume":"35","author":"GT Neske","year":"2015","unstructured":"Neske, G. T., Patrick, S. L. & Connors, B. W. Contributions of diverse excitatory and inhibitory neurons to recurrent network activity in cerebral cortex. J. Neurosci. \n                           35, 1089\u20131105 (2015).","journal-title":"J. Neurosci."},{"key":"3_CR110","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0169-328X(96)00117-9","volume":"42","author":"DG Standaert","year":"1996","unstructured":"Standaert, D. G. et al. Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. Brain. Res. Mol. Brain. Res. \n                           42, 89\u2013102 (1996).","journal-title":"Brain. Res. Mol. Brain. Res."},{"key":"3_CR111","doi-asserted-by":"publisher","first-page":"11534","DOI":"10.1523\/JNEUROSCI.1811-14.2014","volume":"34","author":"M Yamasaki","year":"2014","unstructured":"Yamasaki, M. et al. Opposing role of NMDA receptor GluN2B and GluN2D in somatosensory development and maturation. J. Neurosci. \n                           34, 11534\u201311548 (2014).","journal-title":"J. Neurosci."},{"key":"3_CR112","doi-asserted-by":"crossref","unstructured":"Carlen, M., et al. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol. Psychiatry \n                           17, 537\u2013548\u00a0(2012).","DOI":"10.1038\/mp.2011.31"},{"key":"3_CR113","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nature08002","volume":"459","author":"JA Cardin","year":"2009","unstructured":"Cardin, J. A. et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature \n                           459, 663\u2013667 (2009).","journal-title":"Nature"},{"key":"3_CR114","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nature07991","volume":"459","author":"VS Sohal","year":"2009","unstructured":"Sohal, V. S. et al. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature \n                           459, 698\u2013702 (2009).","journal-title":"Nature"},{"issue":"2","key":"3_CR115","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/HRP.0000000000000110","volume":"24","author":"EM Owens","year":"2016","unstructured":"Owens, E. M. et al. Electrophysiological endophenotypes for schizophrenia. Harv. Rev. Psychiatry \n                           24, 129\u2013147 (2016).","journal-title":"Harv. Rev. Psychiatry"},{"key":"3_CR116","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/aur.1264","volume":"6","author":"JA Saunders","year":"2013","unstructured":"Saunders, J. A. et al. Knockout of NMDA receptors in parvalbumin interneurons recreates autism-like phenotypes. Autism Res. \n                           6, 69\u201377 (2013).","journal-title":"Autism Res."},{"key":"3_CR117","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","volume":"51","author":"K Monory","year":"2006","unstructured":"Monory, K. et al. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. neuron \n                           51, 455\u2013466 (2006).","journal-title":"Neuron"},{"key":"3_CR118","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.biopsych.2012.12.004","volume":"73","author":"Z Jiang","year":"2013","unstructured":"Jiang, Z. et al. Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons. Biol. Psychiatry \n                           73, 1024\u20131034 (2013).","journal-title":"Biol. Psychiatry"},{"key":"3_CR119","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fnins.2014.00168","volume":"8","author":"K Nakao","year":"2014","unstructured":"Nakao, K. & Nakazawa, K. Brain state-dependent abnormal LFP activity in the auditory cortex of a schizophrenia mouse model. Front. Neurosci. \n                           8, 168 (2014).","journal-title":"Front. Neurosci."},{"key":"3_CR120","doi-asserted-by":"crossref","unstructured":"Chung, D.W., K.N. Fish & D.A. Lewis, Pathological basis for deficient excitatory drive to cortical parvalbumin interneurons in schizophrenia. Am. J. Psychiatry\u00a0(2016).173, 1131\u20131139 (2016)","DOI":"10.1176\/appi.ajp.2016.16010025"},{"key":"3_CR121","doi-asserted-by":"crossref","unstructured":"Erhardt, S. et al. The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology \n                           112, 297\u2013306 (2017).","DOI":"10.1016\/j.neuropharm.2016.05.020"},{"key":"3_CR122","doi-asserted-by":"publisher","unstructured":"Her\u00e9di, J. et al. Astrocytic and neuronal localization of kynurenine aminotransferase-2 in the adult mouse brain. Brain Struct. Funct. (2016). doi:10.1007\/s00429-016-1299-5.","DOI":"10.1007\/s00429-016-1299-5"},{"key":"3_CR123","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnins.2014.00012","volume":"8","author":"BM Campbell","year":"2014","unstructured":"Campbell, B. M. et al. Kynurenines in CNS disease: regulation by inflammatory cytokines. Front. Neurosci. \n                           8, 12 (2014).","journal-title":"Front. Neurosci."},{"key":"3_CR124","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fnins.2016.00435","volume":"10","author":"I Bagasrawala","year":"2016","unstructured":"Bagasrawala, I., Zecevic, N. & Radonjic, N. N-methyl D-aspartate receptor antagonist kynurenic acid affects human cortical development. Frontiers in Neuroscience \n                           10, 435 (2016).","journal-title":"Frontiers in Neuroscience"},{"key":"3_CR125","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.steroids.2011.09.002","volume":"76","author":"M Korinek","year":"2011","unstructured":"Korinek, M. et al. Neurosteroid modulation of N-methyl-D-aspartate receptors: Molecular mechanism and behavioral effects. Steroids. \n                           76, 1409\u20131418 (2011).","journal-title":"Steroids."},{"key":"3_CR126","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1210\/jc.2004-0444","volume":"90","author":"A Parizek","year":"2005","unstructured":"Parizek, A. et al. Neuroactive pregnanolone isomers during pregnancy. J. Clin. Endocrinol. Metab. \n                           90, 395\u2013403 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3_CR127","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/sj.bjp.0704543","volume":"135","author":"A Malayev","year":"2002","unstructured":"Malayev, A., Gibbs, T. T. & Farb, D. H. Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br. J. Pharmacol. \n                           135, 901\u2013909 (2002).","journal-title":"Br. J. Pharmacol."},{"key":"3_CR128","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bbr.2012.07.020","volume":"235","author":"K Vales","year":"2012","unstructured":"Vales, K. et al. 3\u03b15\u03b2-Pregnanolone glutamate, a use-dependent NMDA antagonist, reversed spatial learning deficit in an animal model of schizophrenia. Behav. Brain. Res. \n                           235, 82\u201388 (2012).","journal-title":"Behav. Brain. Res."},{"key":"3_CR129","doi-asserted-by":"publisher","first-page":"7222","DOI":"10.1038\/ncomms8222","volume":"6","author":"D Vullhorst","year":"2015","unstructured":"Vullhorst, D. et al. A negative feedback loop controls NMDA receptor function in cortical interneurons via neuregulin 2\/ErbB4 signalling. Nat Commun. 6, 7222 (2015).","journal-title":"Nat Commun"},{"key":"3_CR130","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1176\/appi.ajp.2015.15020150","volume":"173","author":"DW Chung","year":"2016","unstructured":"Chung, D. W. et al. Dysregulated ErbB4 splicing in schizophrenia: Selective effects on parvalbumin expression. Am. J. Psychiatry \n                           173, 60\u201368 (2016).","journal-title":"Am. J. Psychiatry."},{"key":"3_CR131","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nm1418","volume":"12","author":"CG Hahn","year":"2006","unstructured":"Hahn, C. G. et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med. \n                           12, 824\u2013828 (2006).","journal-title":"Nat. Med."},{"key":"3_CR132","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/cercor\/bhs370","volume":"24","author":"JD Murray","year":"2014","unstructured":"Murray, J. D. et al. Linking microcircuit dysfunction to cognitive impairment: effects of disinhibition associated with schizophrenia in a cortical working memory model. Cereb. Cortex. \n                           24, 859\u2013872 (2014).","journal-title":"Cereb. Cortex."},{"key":"3_CR133","doi-asserted-by":"publisher","first-page":"p. e778","DOI":"10.1038\/tp.2016.44","volume":"6","author":"AM Bygrave","year":"2016","unstructured":"Bygrave, A. M. et al. Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801. Transl Psychiatry \n                           6, p. e778 (2016).","journal-title":"Transl Psychiatry"},{"key":"3_CR134","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1073\/pnas.0813415106","volume":"106","author":"LS Zweifel","year":"2009","unstructured":"Zweifel, L. S. et al. Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior. Proc. Natl. Acad. Sci. U. S. A. \n                           106, 7281\u20137288 (2009).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"3_CR135","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.conb.2011.10.018","volume":"22","author":"J Lisman","year":"2012","unstructured":"Lisman, J. Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia? Curr. Opin. Neurobiol. \n                           22, 537\u2013544 (2012).","journal-title":"Curr. Opin. Neurobiol."},{"key":"3_CR136","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/0269881114565805","volume":"29","author":"JA Pratt","year":"2015","unstructured":"Pratt, J. A. & Morris, B. J. The thalamic reticular nucleus: a functional hub for thalamocortical network dysfunction in schizophrenia and a target for drug discovery. J. Psychopharmacol. \n                           29, 127\u2013137 (2015).","journal-title":"J. Psychopharmacol."},{"key":"3_CR137","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.physbeh.2014.04.038","volume":"131","author":"Z Vukadinovic","year":"2014","unstructured":"Vukadinovic, Z. NMDA receptor hypofunction and the thalamus in schizophrenia. Physiol. Behav. \n                           131, 156\u2013159 (2014).","journal-title":"Physiol. Behav."},{"key":"3_CR138","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.conb.2004.05.001","volume":"14","author":"Y Nong","year":"2004","unstructured":"Nong, Y., Huang, Y. -Q. & Salter, M. W. NMDA receptors are movin\u2019 in. Curr. Opin. Neurobiol. \n                           14, 353\u2013361 (2004).","journal-title":"Curr. Opin. Neurobiol."},{"key":"3_CR139","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.tins.2005.03.004","volume":"28","author":"I P\u00e9rez-Ota\u00f1o","year":"2005","unstructured":"P\u00e9rez-Ota\u00f1o, I. & Ehlers, M. D. Homeostatic plasticity and NMDA receptor trafficking. Trends. Neurosci. \n                           28, 229\u2013238 (2005).","journal-title":"Trends. Neurosci."},{"key":"3_CR140","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.1523\/JNEUROSCI.0956-07.2007","volume":"27","author":"VA Alvarez","year":"2007","unstructured":"Alvarez, V. A., Ridenour, D. A. & Sabatini, B. L. Distinct structural and ionotropic roles of NMDA receptors in controlling spine and synapse stability. J. Neurosci. \n                           27, 7365\u20137376 (2007).","journal-title":"J. Neurosci."},{"key":"3_CR141","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1113\/jphysiol.2009.178905","volume":"588","author":"RA McKinney","year":"2010","unstructured":"McKinney, R. A. Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling. J. Physiol. \n                           588, 107\u2013116 (2010).","journal-title":"J. Physiol."},{"key":"3_CR142","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics, C.","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics, C. Biological insights from 108 schizophrenia-associated genetic loci. Nature \n                           511, 421\u2013427 (2014).","journal-title":"Nature"},{"key":"3_CR143","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.schres.2015.07.018","volume":"176","author":"CC Watkins","year":"2016","unstructured":"Watkins, C. C. & Andrews, S. R. Clinical studies of neuroinflammatory mechanisms in schizophrenia. Schizophr. Res. \n                           176, 14\u201322 (2016).","journal-title":"Schizophr. Res."},{"key":"3_CR144","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrn.2015.19","volume":"17","author":"GE Hardingham","year":"2016","unstructured":"Hardingham, G. E. & Do, K. Q. Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis. Nat. Rev. Neurosci. \n                           17, 125\u2013134 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"3_CR145","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuroscience.2005.10.014","volume":"137","author":"P Steullet","year":"2006","unstructured":"Steullet, P. et al. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia. Neuroscience \n                           137, 807\u201319 (2006).","journal-title":"Neuroscience"},{"key":"3_CR146","doi-asserted-by":"publisher","first-page":"6761","DOI":"10.1038\/ncomms7761","volume":"6","author":"PS Baxter","year":"2015","unstructured":"Baxter, P. S. et al. Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system. Nat Commun. \n                           6, 6761 (2015).","journal-title":"Nat Commun."},{"key":"3_CR147","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.biopsych.2012.09.020","volume":"73","author":"JH Cabungcal","year":"2013","unstructured":"Cabungcal, J. H. et al. Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine. Biol. Psychiatry \n                           73, 574\u201382 (2013).","journal-title":"Biol. Psychiatry"},{"key":"3_CR148","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neuroscience.2015.07.038","volume":"309","author":"CA Tamminga","year":"2015","unstructured":"Tamminga, C. A. & Zukin, R. S. Schizophrenia: evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiology. Neuroscience. \n                           309, 233\u2013242 (2015).","journal-title":"Neuroscience."}],"container-title":["npj Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-016-0003-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-016-0003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-016-0003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T20:56:47Z","timestamp":1671742607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-016-0003-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":148,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1038\/s41537-016-0003-3","relation":{},"ISSN":["2334-265X"],"issn-type":[{"value":"2334-265X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]},"assertion":[{"value":"9 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}